You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -5,585.1% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.2 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 371.8 | n/a |
| Price / Book value | 22.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -54.8% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | 0.91 | -3.39 | -3.00p | -29.9 | 0.0 | n/a | n/a | 0.0% |
| 2020-09-30 | 0.46 | -4.95 | -4.70p | -21.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-09-30 | 0.34 | -7.63 | -7.20p | -6.1 | 0.0 | n/a | n/a | 0.0% |
| 2022-09-30 | 0.15 | -7.57 | -6.70p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| Director dealings: Oxford Biodynamics director lowers stake Sharecast News | 20 Oct |
|---|---|
| Oxford BioDynamics secures US billing code for prostate test Sharecast News | 03 Oct |
| Oxford Biodynamics first-half losses widen Sharecast News | 30 May |
| Director/PDMR Shareholding | 13-Nov-23 10:24 |
|---|---|
| Holding(s) in Company | 07-Nov-23 12:30 |
| Holding(s) in Company | 06-Nov-23 17:05 |
| Director/PDMR Shareholding | 03-Nov-23 09:29 |
| PDMR Dealing / Grant of Share Options | 23-Oct-23 11:09 |